Valuation NEOVACS Euronext Paris

Stocks

End-of-day quote Euronext Paris Other stock markets 2024-02-05			5-day change	1st Jan Change
1.980 ^EUR	-1.00%		-1.00%	-1.00%

06-30	Neovacs bolsters its strategic intellectual property portfolio
02-10	Neovacs S.A. announced that it has received ?0.25 million in funding from Hanover Square Investments Pte Limted	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2019	2020	2021	2022	2023	2024
Market Cap ¹	-	-	-	-	-	-
Change	-	-	-	-	-	-
Enterprise Value (EV) ¹	-	-	-	-	-	-
Change	-	-	-	-	-	-
P/E	-96,912,987x	-264,999,452x	-6,728x	-22,860,253x	-	-
PBR	-	-	-	-	-	-
PEG	-	3,273,301.5x	-0x	229,169x	-	-
Capitalization / Revenue	-	-	-	-	-	-
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-	-	-	-	-	-
EV / EBIT	-	-	-	-	-	-
EV / FCF	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0479	-0.009117	-5.946	-0.0147	-	-
Distribution rate	-	-	-	-	-	-
Net sales ¹	0.0952	0.031	0.0225	0.001112	0.5334	0.4339
EBITDA ¹	-8.118	-3.437	-7.728	-6.294	-6.06	-6.43
EBIT ¹	-8.175	-3.492	-7.828	-6.445	-6.908	-6.622
Net income ¹	-7.548	-6.143	-11.84	-3.549	-8.743	-32.91
Net Debt ¹	-1.234	-9.681	-32.06	-5.555	-0.2365	-0.2051
Reference price ²	4,640,000.0000	2,416,000.0000	40,000.0000	336,000.0000	20,000.0000	10,212,000.0000
Nbr of stocks (in thousands)	-	-	-	-	-	-
Announcement Date	4/30/20	6/29/21	5/2/22	4/30/23	4/30/24	4/30/25

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
LONZA GROUP AG	32.9x	5.88x	17.49x	0.97%	48.22B
REVOLUTION MEDICINES, INC.	-22.77x	340.62x	-20.81x	-.--%	38.79B
IQVIA HOLDINGS INC.	29.98x	3x	12.95x	-.--%	38.41B
BEONE MEDICINES AG	46.6x	4.72x	30.74x	-.--%	34.88B
CELLTRION, INC.	27.72x	8.03x	20.18x	0.42%	29.19B
MEDPACE HOLDINGS, INC.	32.6x	5.33x	24.22x	-.--%	16B
EUROFINS SCIENTIFIC SE	22.53x	1.98x	8.57x	1.17%	13.53B
ICON PUBLIC LIMITED COMPANY	24.75x	1.81x	11.1x	-.--%	12.22B
Average	24.29x	46.42x	13.05x	0.32%	28.91B
Weighted average by Cap.	23.43x	61.17x	12.26x	0.32%